NCT01755078View on ClinicalTrials.gov

Long Term Evaluation of Sevelamer HCl vs. Calcium-based Phosphate Binder in the Treatment of Hyperphosphatemia in Hemodialysis Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

166

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
HemodialysisHyperphosphatemiaCardiovascular Events
Interventions
DRUG

Sevelamer HCl

Non-metal phosphate binder

DRUG

Calcium-based phosphate binder

Sponsors
All Listed Sponsors
lead

Chugai Pharma Taiwan

INDUSTRY

NCT01755078 - Long Term Evaluation of Sevelamer HCl vs. Calcium-based Phosphate Binder in the Treatment of Hyperphosphatemia in Hemodialysis Patients | Biotech Hunter | Biotech Hunter